Preeclampsia: Animal models for a human cure
- 13 January 2011
- journal article
- editorial
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 108 (4) , 1197-1198
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse modelProceedings of the National Academy of Sciences, 2010
- A New Mouse Model to Explore Therapies for PreeclampsiaPLOS ONE, 2010
- Using Pravastatin to Improve the Vascular Reactivity in a Mouse Model of Soluble Fms-Like Tyrosine Kinase-1–Induced PreeclampsiaObstetrics & Gynecology, 2010
- Proteases and sFlt-1 Release in the Human PlacentaPlacenta, 2010
- Can the biology of VEGF and haem oxygenases help solve pre-eclampsia?Biochemical Society Transactions, 2009
- Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop preeclampsia later in pregnancy: implications for screeningPrenatal Diagnosis, 2009
- Preeclampsia and Soluble fms-Like Tyrosine Kinase 1The Journal of Clinical Endocrinology & Metabolism, 2009
- Prenatal exposure to HMG-CoA reductase inhibitors: Effects on fetal and neonatal outcomesReproductive Toxicology, 2008
- Complementation of placental defects and embryonic lethality by trophoblast-specific lentiviral gene transferNature Biotechnology, 2007
- The Risk of Preeclampsia Rises with Increasing Prepregnancy Body Mass IndexAnnals of Epidemiology, 2005